Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
AI in Workplace Bill Advances in NJ A New Jersey Senate panel unanimously advanced a bill ( SB 4075 ) that would regulate the use of automated employment decision systems and limit electronic monitoring...
Newsom Vetoes AI-in-Therapy Bill California Gov. Gavin Newsom (D) vetoed a bill ( SB 903 ) that would have restricted the use of artificial intelligence in psychotherapy. Among other things, it would...
After years of directing how pharmacy benefit managers (PBMs) reimburse pharmacies and administer prescription drug benefits, Arkansas legislators took their oversight a step further last year and sought...
CA Gov Takes Action on AI Safety Following recent reports of security incidents involving artificial intelligence, California Gov. Gavin Newsom (D) issued an executive order directing state officials...
CA Mental Health Professionals Urge Enactment of Bill Restricting AI Therapy Chatbots Over 1,500 mental health professionals in California signed a letter urging Gov. Gavin Newsom (D) to sign a bill...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
The Michigan Senate’s Health Policy Committee has advanced a trio of bipartisan bills aimed at reducing the burden of medical costs on residents of the state. SB 449, SB 450 and SB 451 would require hospitals to implement a financial assistance program allowing patients who are uninsured and have annual incomes at or below 350% of the federal poverty line to receive discounts of up to 100% for services and require consumer reporting agencies to keep medical debt information off credit reports. (MLIVE)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.